Strategic Partnership Advances Wearable Medical Devices
By HospiMedica International staff writers Posted on 17 Nov 2014 |
Welch Allyn (Skaneateles Falls, NY, USA), a leading medical diagnostic device company, and Gentag (Washington DC, USA), a pioneer in disposable biosensors, have announced a strategic development agreement.
Under the terms of the agreement, Welch Allyn and Gentag will collaborate to bring to market near field communication (NFC) devices that will be integrated into medical devices and sensors. The short-range wireless communication uses an antenna that is much smaller than the wavelength of the carrier signal. As a result, NFC communicates either by a modulated electric field, or a modulated magnetic field, but not by radio electromagnetic waves. For example, a small loop antenna produces a magnetic field, which can then be picked up by another small loop antenna, if it is near enough.
The partnership will enable Welch Allyn to offer solutions for remote patient monitoring worldwide by combining Gentag's NFC technology and integrated, ultrathin, battery-less wireless sensors into various medical diagnostic devices and applications. The collaboration is expected to create a range of significant opportunities for workflow efficiency gains and faster availability of clinical information in the Electronic Health Record (EHR).
“This collaborative opportunity will enable Welch Allyn to provide clinicians with smart monitoring solutions and improve patient access to cutting edge diagnostics,” said Stephen Meyer, president and CEO of Welch Allyn.
“Welch Allyn has the knowledge, expertise, and global market reach that will allow the globalization of NFC technologies in medical diagnostic settings,” said John Peeters, CEO of Gentag. “By combining our intellectual property and technology portfolios with Welch Allyn, we feel that patients will be better served by the worldwide availability of high quality wireless medical devices.”
The use of wearable remote patient monitoring (RPM) biosensors that allow constant monitoring of physiological signals is becoming essential for the advancement of both the diagnosis and treatment of diseases. RPM systems allow physicians to overcome the limitations of technology and provide a response to the need for monitoring individuals over weeks or months. The data sets recorded using these systems are then processed to detect events predictive of possible worsening of the patient’s clinical situations, as well as assess the impact of clinical interventions.
Related Links:
Welch Allyn
Gentag
Under the terms of the agreement, Welch Allyn and Gentag will collaborate to bring to market near field communication (NFC) devices that will be integrated into medical devices and sensors. The short-range wireless communication uses an antenna that is much smaller than the wavelength of the carrier signal. As a result, NFC communicates either by a modulated electric field, or a modulated magnetic field, but not by radio electromagnetic waves. For example, a small loop antenna produces a magnetic field, which can then be picked up by another small loop antenna, if it is near enough.
The partnership will enable Welch Allyn to offer solutions for remote patient monitoring worldwide by combining Gentag's NFC technology and integrated, ultrathin, battery-less wireless sensors into various medical diagnostic devices and applications. The collaboration is expected to create a range of significant opportunities for workflow efficiency gains and faster availability of clinical information in the Electronic Health Record (EHR).
“This collaborative opportunity will enable Welch Allyn to provide clinicians with smart monitoring solutions and improve patient access to cutting edge diagnostics,” said Stephen Meyer, president and CEO of Welch Allyn.
“Welch Allyn has the knowledge, expertise, and global market reach that will allow the globalization of NFC technologies in medical diagnostic settings,” said John Peeters, CEO of Gentag. “By combining our intellectual property and technology portfolios with Welch Allyn, we feel that patients will be better served by the worldwide availability of high quality wireless medical devices.”
The use of wearable remote patient monitoring (RPM) biosensors that allow constant monitoring of physiological signals is becoming essential for the advancement of both the diagnosis and treatment of diseases. RPM systems allow physicians to overcome the limitations of technology and provide a response to the need for monitoring individuals over weeks or months. The data sets recorded using these systems are then processed to detect events predictive of possible worsening of the patient’s clinical situations, as well as assess the impact of clinical interventions.
Related Links:
Welch Allyn
Gentag
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures